Connor, Clark & Lunn Investment Management Ltd. Oric Pharmaceuticals, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 12,832 shares of ORIC stock, worth $109,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,832Holding current value
$109,072% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ORIC
# of Institutions
124Shares Held
66.6MCall Options Held
7.8KPut Options Held
700-
Nextech Invest Ag5.29MShares$44.9 Million8.84% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$41.1 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$37.4 Million4.67% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$35.2 Million2.29% of portfolio
-
Viking Global Investors LP4MShares$34 Million0.16% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $336M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...